What if you'd held KRYS?
A $1,000 investment in Krystal Biotech, Inc. (KRYS) at the month-end close of 2017-09 would be worth $34,437 at the close of 2026-08 — +3343.7% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $3,059.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2017
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2017 | $1,000 | — |
| 2018 | $1,975 | +97.5% |
| 2019 | $5,264 | +166.5% |
| 2020 | $5,703 | +8.3% |
| 2021 | $6,649 | +16.6% |
| 2022 | $7,530 | +13.3% |
| 2023 | $11,793 | +56.6% |
| 2024 | $14,892 | +26.3% |
| 2025 | $23,435 | +57.4% |
| 2026 | $32,637 | +39.3% |
Best and worst month-end to buy
The best single month-end close to have bought KRYS was 2018-04 ($9.61): $1,000 then is $35,727 today. The worst was 2026-06 ($372): $1,000 then is $924.
FAQ
What would $1,000 in KRYS be worth today?
A $1,000 investment in Krystal Biotech, Inc. (KRYS) at the start of 2017 would be worth about $34,437 today, a total return of +3343.7%. Dividends are reinvested in these figures.
What were the best and worst years for KRYS?
Krystal Biotech, Inc. (KRYS)'s strongest calendar year since 2017 was 2019, a +166.5% return — $1,000 held through that year became about $2,665 by year-end. Its weakest year was 2020, at +8.3%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in KRYS have grown?
Investing $100 at the end of every month since 2017-09 would have grown to about $86,134 on $10,800 invested.
Did KRYS beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $3,059. KRYS beat the S&P 500 by +1025.6% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Krystal Biotech, Inc. (KRYS) historical total-return data from 2017-09 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.